Intuitive Surgical, Inc. (ISRG) Quarterly Net Income
The quarterly net income for Intuitive Surgical, Inc. (ISRG) is $821.50M with a period-over-period change of +3.36%. Quarterly net income is profit after expenses, taxes, interest, and other items for the latest fiscal quarter.
ISRG Quarterly Net Income Chart
Quarterly Net Income History
| Date | Quarterly Net Income | % Change |
|---|---|---|
| Q1 2026 | $821.50M | +3.36% |
| Q4 2025 | $794.80M | +12.83% |
| Q3 2025 | $704.40M | +6.99% |
| Q2 2025 | $658.40M | (5.73%) |
| Q1 2025 | $698.40M | +1.85% |
| Q4 2024 | $685.70M | +21.34% |
| Q3 2024 | $565.10M | +7.25% |
| Q2 2024 | $526.90M | (3.30%) |
| Q1 2024 | $544.90M | (10.11%) |
| Q4 2023 | $606.20M | +45.83% |
| Q3 2023 | $415.70M | (1.21%) |
| Q2 2023 | $420.80M | +18.44% |
| Q1 2023 | $355.30M | +9.36% |
| Q4 2022 | $324.90M | +0.28% |
| Q3 2022 | $324.00M | +5.26% |
| Q2 2022 | $307.80M | (15.81%) |
| Q1 2022 | $365.60M | (3.94%) |
| Q4 2021 | $380.60M | +0.03% |
| Q3 2021 | $380.50M | (26.43%) |
| Q2 2021 | $517.20M | +21.32% |
| Q1 2021 | $426.30M | +16.73% |
| Q4 2020 | $365.20M | +16.34% |
| Q3 2020 | $313.90M | +361.62% |
| Q2 2020 | $68.00M | (78.31%) |
| Q1 2020 | $313.50M | (12.36%) |
| Q4 2019 | $357.70M | (9.85%) |
| Q3 2019 | $396.80M | +24.66% |
| Q2 2019 | $318.30M | +3.85% |
| Q1 2019 | $306.50M | +4.79% |
| Q4 2018 | $292.50M | +0.00% |
| Q3 2018 | $292.50M | +14.57% |
| Q2 2018 | $255.30M | (11.23%) |
| Q1 2018 | $287.60M | +841.24% |
| Q4 2017 | ($38.80M) | (113.04%) |
| Q3 2017 | $297.50M | +34.31% |
| Q2 2017 | $221.50M | +23.19% |
| Q1 2017 | $179.80M | (11.86%) |
| Q4 2016 | $204.00M | (3.32%) |
| Q3 2016 | $211.00M | +14.36% |
| Q2 2016 | $184.50M | +35.26% |
| Q1 2016 | $136.40M | (28.21%) |
| Q4 2015 | $190.00M | +13.57% |
| Q3 2015 | $167.30M | +24.39% |
| Q2 2015 | $134.50M | +38.66% |
| Q1 2015 | $97.00M | (33.92%) |
| Q4 2014 | $146.80M | +18.67% |
| Q3 2014 | $123.70M | +18.94% |
| Q2 2014 | $104.00M | +134.76% |
| Q1 2014 | $44.30M | (73.35%) |
| Q4 2013 | $166.20M | +5.99% |
| Q3 2013 | $156.80M | (1.45%) |
| Q2 2013 | $159.10M | (15.78%) |
| Q1 2013 | $188.90M | +8.00% |
| Q4 2012 | $174.90M | (4.58%) |
| Q3 2012 | $183.30M | +18.33% |
| Q2 2012 | $154.90M | +7.94% |
| Q1 2012 | $143.50M | (5.09%) |
| Q4 2011 | $151.20M | +23.53% |
| Q3 2011 | $122.40M | +4.26% |
| Q2 2011 | $117.40M | +12.78% |
| Q1 2011 | $104.10M | (14.11%) |
| Q4 2010 | $121.20M | +39.95% |
| Q3 2010 | $86.60M | (2.37%) |
| Q2 2010 | $88.70M | +3.99% |
| Q1 2010 | $85.30M | +9.99% |
| Q4 2009 | $77.55M | +20.19% |
| Q3 2009 | $64.52M | +3.42% |
| Q2 2009 | $62.39M | +121.69% |
| Q1 2009 | $28.14M | (44.56%) |
| Q4 2008 | $50.76M | (11.87%) |
| Q3 2008 | $57.59M | +12.53% |
| Q2 2008 | $51.18M | +14.29% |
| Q1 2008 | $44.78M | (8.89%) |
| Q4 2007 | $49.15M | +20.12% |
| Q3 2007 | $40.92M | +33.45% |
| Q2 2007 | $30.66M | +28.83% |
| Q1 2007 | $23.80M | +0.68% |
| Q4 2006 | $23.64M | +36.95% |
| Q3 2006 | $17.26M | +3.48% |
| Q2 2006 | $16.68M | +15.38% |
| Q1 2006 | $14.46M | (70.81%) |
| Q4 2005 | $49.53M | +139.03% |
| Q3 2005 | $20.72M | +40.15% |
| Q2 2005 | $14.78M | +62.39% |
| Q1 2005 | $9.10M | (22.07%) |
| Q4 2004 | $11.68M | +91.10% |
| Q3 2004 | $6.11M | +26.56% |
| Q2 2004 | $4.83M | +466.24% |
| Q1 2004 | $853,000 | +117.57% |
| Q4 2003 | ($4.86M) | (44.80%) |
| Q3 2003 | ($3.35M) | (481.89%) |
| Q2 2003 | $878,000 | +138.29% |
| Q1 2003 | ($2.29M) | +11.81% |
| Q4 2002 | ($2.60M) | +59.78% |
| Q3 2002 | ($6.46M) | (72.83%) |
| Q2 2002 | ($3.74M) | - |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa